These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9840945

  • 1. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
    de Jong R, van Wijk A, Heisterkamp N, Groffen J.
    Oncogene; 1998 Nov 26; 17(21):2805-10. PubMed ID: 9840945
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R, ten Hoeve J, Heisterkamp N, Groffen J.
    Oncogene; 1997 Feb 06; 14(5):507-13. PubMed ID: 9053848
    [Abstract] [Full Text] [Related]

  • 3. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
    Cho YJ, Hemmeryckx B, Groffen J, Heisterkamp N.
    Biochem Biophys Res Commun; 2005 Aug 12; 333(4):1276-83. PubMed ID: 15982636
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the adapter protein CRKL in integrin-mediated adhesion.
    Uemura N, Salgia R, Ewaniuk DS, Little MT, Griffin JD.
    Oncogene; 1999 Jun 03; 18(22):3343-53. PubMed ID: 10362355
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine phosphorylation of murine Crkl.
    de Jong R, Haataja L, Voncken JW, Heisterkamp N, Groffen J.
    Oncogene; 1995 Oct 19; 11(8):1469-74. PubMed ID: 7478571
    [Abstract] [Full Text] [Related]

  • 6. Cellular interactions of CRKL, and SH2-SH3 adaptor protein.
    ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J.
    Cancer Res; 1994 May 15; 54(10):2563-7. PubMed ID: 8168080
    [Abstract] [Full Text] [Related]

  • 7. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
    Posern G, Zheng J, Knudsen BS, Kardinal C, Müller KB, Voss J, Shishido T, Cowburn D, Cheng G, Wang B, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zamborelli TJ, Adermann K, Hanafusa H, Feller SM.
    Oncogene; 1998 Apr 16; 16(15):1903-12. PubMed ID: 9591773
    [Abstract] [Full Text] [Related]

  • 8. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G.
    Arai A, Nosaka Y, Kohsaka H, Miyasaka N, Miura O.
    Blood; 1999 Jun 01; 93(11):3713-22. PubMed ID: 10339478
    [Abstract] [Full Text] [Related]

  • 9. Crk family adaptors-signalling complex formation and biological roles.
    Feller SM.
    Oncogene; 2001 Oct 01; 20(44):6348-71. PubMed ID: 11607838
    [Abstract] [Full Text] [Related]

  • 10. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.
    Gutiérrez-Berzal J, Castellano E, Martín-Encabo S, Gutiérrez-Cianca N, Hernández JM, Santos E, Guerrero C.
    Exp Cell Res; 2006 Apr 01; 312(6):938-48. PubMed ID: 16443220
    [Abstract] [Full Text] [Related]

  • 11. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD.
    J Biol Chem; 1996 Oct 11; 271(41):25198-203. PubMed ID: 8810278
    [Abstract] [Full Text] [Related]

  • 12. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT, de Jong R, Park RK, Liu Y, Heisterkamp N, Groffen J, Durden DL.
    J Immunol; 1998 Nov 15; 161(10):5555-63. PubMed ID: 9820532
    [Abstract] [Full Text] [Related]

  • 13. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N, Salgia R, Li JL, Pisick E, Sattler M, Griffin JD.
    Leukemia; 1997 Mar 15; 11(3):376-85. PubMed ID: 9067577
    [Abstract] [Full Text] [Related]

  • 14. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
    I ST, Nie Z, Stewart A, Najdovska M, Hall NE, He H, Randazzo PA, Lock P.
    J Cell Sci; 2004 Dec 01; 117(Pt 25):6071-84. PubMed ID: 15546919
    [Abstract] [Full Text] [Related]

  • 15. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM, Posern G, Voss J, Kardinal C, Sakkab D, Zheng J, Knudsen BS.
    J Cell Physiol; 1998 Dec 01; 177(4):535-52. PubMed ID: 10092207
    [Abstract] [Full Text] [Related]

  • 16. Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.
    Hemmeryckx B, van Wijk A, Reichert A, Kaartinen V, de Jong R, Pattengale PK, Gonzalez-Gomez I, Groffen J, Heisterkamp N.
    Cancer Res; 2001 Feb 15; 61(4):1398-405. PubMed ID: 11245441
    [Abstract] [Full Text] [Related]

  • 17. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J, Posern G, Hannemann JR, Wiedemann LM, Turhan AG, Poirel H, Bernard OA, Adermann K, Kardinal C, Feller SM.
    Oncogene; 2000 Mar 23; 19(13):1684-90. PubMed ID: 10763825
    [Abstract] [Full Text] [Related]

  • 18. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways.
    Feller SM, Knudsen B, Hanafusa H.
    Oncogene; 1995 Apr 20; 10(8):1465-73. PubMed ID: 7731701
    [Abstract] [Full Text] [Related]

  • 19. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M, Salgia R.
    Leukemia; 1998 May 20; 12(5):637-44. PubMed ID: 9593259
    [Abstract] [Full Text] [Related]

  • 20. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins.
    Oehrl W, Kardinal C, Ruf S, Adermann K, Groffen J, Feng GS, Blenis J, Tan TH, Feller SM.
    Oncogene; 1998 Oct 15; 17(15):1893-901. PubMed ID: 9788432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.